Non-Scarring Hair Loss (Non-Scarring Alopecia)

Non-scarring alopecia refers to a group of hair loss disorders in which hair follicles are not permanently destroyed and no scarring (fibrosis) is observed on the scalp. This type of hair loss is typically reversible, and hair may regrow with treatment of the underlying cause. Non-scarring alopecia occurs in both men and women and can affect quality of life to varying degrees. The most common forms include androgenetic alopecia, alopecia areata, telogen effluvium, and traumatic alopecia.

Non-scarring alopecia can occur in any age group and does not discriminate by sex. However, certain forms are more prevalent in specific age groups or genders. For example, androgenetic alopecia is more common in men, while telogen effluvium is frequently observed in women. Non-scarring alopecia can be classified as follows:

The pathophysiology of non-scarring alopecia varies depending on the underlying condition:

• Androgenetic Alopecia: Miniaturization of hair follicles and shortening of the hair growth cycle due to the effects of androgens, particularly dihydrotestosterone (DHT).
• Alopecia Areata: Lymphocytic infiltration targeting hair follicles as a result of autoimmune processes.
• Telogen Effluvium: Sudden shift of a large number of hair follicles into the telogen (resting) phase, leading to shedding.
• Traumatic Alopecia: Mechanical or chemical damage to hair follicles.

Non-scarring alopecia presents clinically in various patterns:

• In men: Receding hairline (frontal recession) and thinning at the vertex.
• In women: Generalized hair thinning with prominent diffuse loss at the crown.

• Round or oval-shaped, well-demarcated areas of hair loss on the scalp.
• Occasionally, loss of eyebrows, eyelashes, or body hair may occur.

• Generalized thinning and reduced hair density.
• Hairs shed easily upon gentle traction or brushing.

• Traction Alopecia: Hair loss along the hairline due to chronic tension from tight hairstyles.
• Trichotillomania: Irregular patches of hair loss caused by the patient’s compulsive hair pulling.

The diagnosis of non-scarring alopecia is primarily based on clinical examination and patient history. The following methods may be used to confirm the diagnosis:

• Hair Pull Test: Assesses whether hairs are easily shed.
• Trichoscopy: Dermatoscopic evaluation of the scalp and hair follicles.
• Laboratory Tests: To investigate hormonal imbalances or systemic diseases (e.g., thyroid function tests, serum ferritin levels).
• Biopsy: Rarely required; occasionally used in the diagnosis of alopecia areata.

The treatment of non-scarring alopecia is tailored to the underlying cause and severity of the condition.

• Topical Treatments: Minoxidil (2% or 5%) stimulates hair growth.
• Oral Treatments: Finasteride (for men) reduces androgen activity.
• In women: Antiandrogens (e.g., spironolactone) or oral contraceptives.

• Topical Corticosteroids: Reduce inflammation.
• Intralesional Corticosteroid Injections: Used for localized lesions.
• Systemic Treatments: Corticosteroids or immunomodulators (e.g., methotrexate, cyclosporine) for severe cases.

• Treatment of Underlying Cause: Stress management, correction of iron deficiency, and treatment of hormonal disturbances.
• Supportive Therapies: Vitamins that support hair growth (e.g., biotin, zinc).

• Traction Alopecia: Preventive measures to avoid tight hairstyles and mechanical stress on hair.
• Trichotillomania: Psychotherapy or behavioral therapy.